OMIC (singulargenomics.com) Company Net Assets

Public company logo of Singular Genomics (OMIC)

The daily price chart for Singular Genomics Systems (OMIC) clearly illustrates the impact of geopolitical disruptions, which block the export of precision instruments and hinder genetic research in closed regions. Meanwhile, the indicator stands at 0.12. Stable business revenue is secured through the management of optics supply chains and collaboration with various contractors. Cost optimization is achieved via in-house production of systems while delegating the manufacturing of standard microchips to third-party partners.

singulargenomics.com (OMIC) - Company Book Value from 07/04/2022 to 03/01/2025

Singular Genomics (OMIC) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Singular Genomics Corp|OMIC - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Singular Genomics Systems, Inc.|OMIC - Enterprise Value
- book capitalization data:
Equity per Share Singular Genomics|OMIC - Company Book Value|Capitalization to Book Value Ratio singulargenomics.com|OMIC - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Singular Genomics Systems|OMIC - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Singular Genomics Systems, Inc.|OMIC - Company Aggregate Debts|Debts to Net Assets Singular Genomics Systems, Inc.
Summary company analytics:Singular Genomics Corp - OMIC
Flagship merchandise of Singular Genomics Systems Inc

Book value capitalization reflects the value of the company's net assets minus all liabilities, serving as a conservative measure of a business's real value during periods of market volatility. An analysis of the current book value capitalization allows for an assessment of how recurring revenues from the sale of sequencing consumables strengthen the asset base of Singular Genomics Systems (OMIC), ensuring the long-term sustainability of free cash flow.

Main competitors

TEM - Book Valuation of Business|QGEN (Qiagen N.V.) - Book Capitalization|ionispharma.com (IONS) - Company Net Assets|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|beamtx.com - Book Capitalization|Company Book Value SRPT (Sarepta)|TWST - Book Valuation of Business|10x Genomics Corp - Book Capitalization|NTLA (Intellia Corp) - Book Valuation of Business|Company Book Value Stoke Therapeutics (STOK)|Accounting Capitalization biolifesolutions.com|WVE: Book Capitalization|Book Value of Business Maze Therapeutics, Inc. MAZE|Company Net Assets SION (Sionna Pharma)|Prime Medicine Bio - Book Capitalization|TSHA - Company Book Value|QURE - Company Book Value|MGTX: Book Capitalization|RGNX (REGENXBIO Inc) - Book Capitalization|SLDB - Company Book Value|Accounting Value of Company Ocugen Pharma (OCGN)|Pacific Biosciences (PACB) - Company Net Assets|Accounting Value of Company benitec.com (BNTC)|DSGN (Design Therapeutics, Inc.) - Book Capitalization|Book Value of Business Rocket Pharma RCKT|FDMT (4D Molecular Therapeutics Inc) - Book Capitalization|LXEO: Total Stockholders' Equity|Company Book Value korrobio.com|EDIT (editasmedicine.com) - Accounting Capitalization|Company Book Value SLN (Silence Therapeutics plc)|Total Stockholders' Equity PRQR|Company Book Value CDXS (Codexis, Inc.)|Company Net Assets Sangamo BioSciences (SGMO)|Book Capitalization NAUT|Book Valuation of Business metagenomi.co MGX|DTIL: Book Capitalization|GBIO: Company Net Assets|Boundless Bio, Inc - Company Book Value|Book Valuation of Business Exicure|IMNN - Company Net Assets|Accounting Value of Company PHIO|MBIO (Mustang Bio, Inc.) - Company Book Value|Book Valuation of Business transcodetherapeutics.com RNAZ|BNGO: Company Net Assets|Applied DNA Corp - Total Stockholders' Equity|Company Book Value BLUE (bluebird bio, Inc.)|ImmunoPrecise Antibodies (IPA) - Book Valuation of Business|OMGA - Company Net Assets|Regulus Therapeutics, Inc. (RGLS) - Total Net Assets|Book Capitalization SYRS (Syros)|Total Stockholders' Equity TBIO|Company Book Value TCON (TRACON Pharmaceuticals)|Company Net Assets UBX (unitybiotechnology.com)